{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:35:39Z","timestamp":1787312139830,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ygyno.2014.07.099","type":"journal-article","created":{"date-parts":[[2014,8,2]],"date-time":"2014-08-02T17:02:04Z","timestamp":1406998924000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1054-7750","authenticated-orcid":false,"given":"M.J.","family":"Rutten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.L.","family":"Boldingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Trum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.W.J.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Kenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Buist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0005","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0010","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"issue":"5","key":"10.1016\/j.ygyno.2014.07.099_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.07.099_bb0020","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2014.07.099_bb0025","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"10.1016\/j.ygyno.2014.07.099_bb0030","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2014.07.099_bb0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances","volume":"40","author":"Gilks","year":"2009","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.07.099_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/annonc\/mdq577","article-title":"Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity","volume":"22","author":"Gallagher","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0045","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2007.09.020","article-title":"Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma","volume":"108","author":"Chi","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"22","key":"10.1016\/j.ygyno.2014.07.099_bb0055","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1200\/JCO.2007.11.0114","article-title":"PIEPOC: a new prognostic index for advanced epithelial ovarian cancer\u2014Japan Multinational Trial Organization OC01-01","volume":"25","author":"Teramukai","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.07.099_bb0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1471-0528.2008.02033.x","article-title":"The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma","volume":"116","author":"Gerestein","year":"2009","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2011.12.423","article-title":"Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.07.099_bb0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2014.07.099_bb0190","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2014.07.099_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1008343015697","article-title":"Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?","volume":"10","author":"Eisenhauer","year":"1999","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.07.099_bb0090","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005343.pub3","article-title":"Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer","volume":"8","author":"Morrison","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ygyno.2014.07.099_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.05.001","article-title":"Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer","volume":"69","author":"Gadducci","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.07.099_bb0110","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bjc.1995.539","article-title":"Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials","volume":"72","author":"Warwick","year":"1995","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2014.07.099_bb0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ygyno.2014.07.099_bb0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.07.099_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The LASSO method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0130","series-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2009"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a gynecologic oncology group study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ygyno.2014.07.099_bb0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1054\/bjoc.2001.2030","article-title":"A prognostic model for ovarian cancer","volume":"85","author":"Clark","year":"2001","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.07.099_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bjc.2013.717","article-title":"External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer","volume":"110","author":"van de Laar","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0155","doi-asserted-by":"crossref","first-page":"b605","DOI":"10.1136\/bmj.b605","article-title":"Prognosis and prognostic research: validating a prognostic model","volume":"338","author":"Altman","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2014.07.099_bb0160","unstructured":"Previs R, Bevis K, Huh W, Tillmanns T, Perry L, Moore K, et al. A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy. Gynecologic Oncology(0)."},{"issue":"Suppl. 3(0)","key":"10.1016\/j.ygyno.2014.07.099_bb0200","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S0959-8049(11)70154-X","article-title":"Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer","volume":"47","author":"Ledermann","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.07.099_bb0170","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.07.099_bb0175","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ygyno.2013.05.021","article-title":"Low-grade serous carcinoma: new concepts and emerging therapies","volume":"130","author":"Romero","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2014.07.099_bb0180","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/bjc.2011.455","article-title":"Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers","volume":"105","author":"Braicu","year":"2011","journal-title":"Br J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814012220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814012220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T01:52:41Z","timestamp":1538358761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814012220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0090825814012220"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.07.099","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.07.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}